ACSL (6232) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
13 Nov, 2026Executive summary
9M revenue rose 84.0% YoY to JPY 2.294bn, led by North America; gross margin reached 33.7%, up 24.8 pts YoY.
Revenue plus FY26 backlog and post-Q3 orders totaled JPY 4.025bn, or 100.6% of the JPY 4.0bn full-year forecast.
Operating loss excluding SBIR costs narrowed JPY 575mn YoY to JPY 224mn; reported operating loss was JPY 456mn, and parent net loss was JPY 197mn.
Financial highlights
Gross profit was JPY 773mn, versus JPY 111mn a year earlier; reported SG&A declined to JPY 1,229mn from JPY 1,461mn.
SG&A excluding SBIR costs was JPY 997mn, up JPY 86mn YoY.
Ordinary loss narrowed to JPY 559mn from JPY 738mn; loss before income taxes was JPY 154mn versus JPY 989mn.
Q3 standalone revenue was JPY 646mn, ~2.4x YoY; North America contributed ~80% of quarterly revenue.
Outlook and guidance
FY26 guidance remains net sales of JPY 4.0bn, operating loss of JPY 1.36bn, ordinary loss of JPY 950mn and parent net loss of JPY 600mn.
Q4 gross margin is expected to be lower due to product mix; the full-year gross margin forecast remains 27.5%.
Q4 SG&A excluding SBIR is implied at ~JPY 0.86bn; R&D and outsourced development costs are expected to concentrate in Q4.
Operating profitability excluding national projects is targeted by FY28/12; JPY 5.0bn revenue and 40% gross margin are cited as one benchmark.
Latest events from ACSL
- Revenue up 68.9% YoY, but net loss persists amid fraud-related costs and higher expenses.6232
Q2 2026 - Q1 revenue fell 12% YoY, but gross margin surged and defense orders drove backlog growth.6232
Q1 2026 - Losses narrowed, equity strengthened, and FY26 forecasts strong sales growth and margin gains.6232
Q4 2025 - FY25 revenue grew to JPY 2.59 bn, with strong U.S. and defense sector expansion and improved margins.6232
Investor presentation - Sales revised down on U.S. delays, but losses narrowed and guidance remains cautious.6232
Q3 2025 - Sales soared 291% year-over-year, but losses deepened despite improved gross margin.6232
Q2 2024 - Sales up 224% YoY, backlog strong, but heavy losses and capital adequacy fell.6232
Q3 2024 - Sales soared 196% YoY, but losses and capital adequacy concerns remain.6232
Q4 2024 - Q1 sales soared and losses narrowed, with strong growth and profitability forecast for FY25.6232
Q1 2025